MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation
NYSE:MOH • US60855R1005
Current stock price
139.41 USD
-2.8 (-1.97%)
At close:
140.23 USD
+0.82 (+0.59%)
After Hours:
This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. MOH Profitability Analysis
1.1 Basic Checks
- In the past year MOH was profitable.
- In the past year MOH has reported a negative cash flow from operations.
- Each year in the past 5 years MOH has been profitable.
- MOH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of MOH (3.03%) is better than 64.36% of its industry peers.
- MOH has a better Return On Equity (11.60%) than 77.23% of its industry peers.
- MOH has a better Return On Invested Capital (7.39%) than 69.31% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MOH is significantly above the industry average of 8.94%.
- The last Return On Invested Capital (7.39%) for MOH is well below the 3 year average (14.32%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROIC | 7.39% |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
1.3 Margins
- With a Profit Margin value of 1.04%, MOH perfoms like the industry average, outperforming 56.44% of the companies in the same industry.
- MOH's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 1.73%, MOH perfoms like the industry average, outperforming 47.52% of the companies in the same industry.
- MOH's Operating Margin has declined in the last couple of years.
- The Gross Margin of MOH (13.07%) is worse than 67.33% of its industry peers.
- In the last couple of years the Gross Margin of MOH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% |
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
2. MOH Health Analysis
2.1 Basic Checks
- MOH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- MOH has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, MOH has less shares outstanding
- Compared to 1 year ago, MOH has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.18 indicates that MOH is not in any danger for bankruptcy at the moment.
- MOH has a better Altman-Z score (4.18) than 77.23% of its industry peers.
- A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.97, MOH is in line with its industry, outperforming 41.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.18 |
ROIC/WACC0.92
WACC8.05%
2.3 Liquidity
- A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
- MOH has a better Current ratio (1.69) than 69.31% of its industry peers.
- MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
- MOH's Quick ratio of 1.69 is fine compared to the rest of the industry. MOH outperforms 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 |
3. MOH Growth Analysis
3.1 Past
- The earnings per share for MOH have decreased strongly by -52.98% in the last year.
- MOH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.02% yearly.
- Looking at the last year, MOH shows a quite strong growth in Revenue. The Revenue has grown by 11.75% in the last year.
- Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 18.52% on average per year.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
3.2 Future
- MOH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
- Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.17% on average per year.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. MOH Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 13.09, which indicates a correct valuation of MOH.
- Based on the Price/Earnings ratio, MOH is valued cheaper than 85.15% of the companies in the same industry.
- MOH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
- MOH is valuated rather expensively with a Price/Forward Earnings ratio of 17.93.
- Based on the Price/Forward Earnings ratio, MOH is valued a bit cheaper than 61.39% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (23.28), we can say MOH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.09 | ||
| Fwd PE | 17.93 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -1.01 |
4.3 Compensation for Growth
- MOH's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%
5. MOH Dividend Analysis
5.1 Amount
- No dividends for MOH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MOH Fundamentals: All Metrics, Ratios and Statistics
139.41
-2.8 (-1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-22 2026-04-22/amc
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.18B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (12.38%)
Short Float %6.99%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-29.32%
EPS NQ rev (3m)-38.77%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.09 | ||
| Fwd PE | 17.93 | ||
| P/S | 0.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.76 | ||
| P/tB | 3.83 | ||
| EV/EBITDA | -1.01 |
EPS(TTM)10.65
EY7.64%
EPS(NY)7.78
Fwd EY5.58%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.03% | ||
| ROE | 11.6% | ||
| ROCE | 9.57% | ||
| ROIC | 7.39% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 1.73% | ||
| PM (TTM) | 1.04% | ||
| GM | 13.07% | ||
| FCFM | N/A |
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.03 | ||
| Cap/Depr | 51.79% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 4.33 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.18 |
F-Score4
WACC8.05%
ROIC/WACC0.92
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A
MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?
ChartMill assigns a fundamental rating of 4 / 10 to MOH.
What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?
ChartMill assigns a valuation rating of 3 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.
How profitable is MOLINA HEALTHCARE INC (MOH) stock?
MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for MOH stock?
The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.09 and the Price/Book (PB) ratio is 1.76.